Article

Delicate and thin fibrous septa indicate a regression tendency in metabolic dysfunction-associated steatohepatitis patients with advanced fibrosis

2024-05-23

Abstract excerpt

<title>Abstract</title> <p><bold>Background and Aims:</bold> Metabolic dysfunction-associated steatohepatitis (MASH)-related fibrosis is reversible. However, the dynamic morphology change in fibrosis regression remains unclear. We aim to explore the morphological characteristics of fibrosis regression in advanced MASH patients. <bold>Methods</bold> Clinical and histological data of 79 biopsy-proved MASH patients...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a72b9c65-132f-5e80-a257-d6b334f65e5e
DOI: 10.21203/rs.3.rs-4392304/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Delicate and thin fibrous septa indicate a regression tendency in metabolic dysfunction-associated steatohepatitis patients with advanced fibrosisDOI 10.21203/rs.3.rs-4392304/v1Read

Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)Semantic proximity Read

Persistent steatosis retards fibrosis regression during anti-HBV treatment in patients with chronic HBV infectionSemantic proximity Read

AI-based phenotyping of hepatic fiber morphology to inform molecular alterations in metabolic dysfunction-associated steatotic liver disease.Semantic proximity Read

Quantitative fibrosis features from digitized H&E-stained liver biopsies reveal granular insights into fibrosis and disease progression in metabolic dysfunction-associated steatohepatitis: a retrospective analysis of STELLAR-3 and STELLAR-4Semantic proximity Read

Current Insights into Liver Fibrosis: Epidemiological Patterns, Etiopathogenesis, Clinical Correlates, and Research AgendaSemantic proximity Read

Spatial and Single‐Cell Transcriptomics Reveals the Regional Division of the Spatial Structure of MASH FibrosisSemantic proximity Read

An Invisible Early Steatosis Phenotype Defined for a Large Population-Based CohortSemantic proximity Read

FIB-4 First in Diagnostic Algorithm of MAFLD at the Era of “Global Metabodemic “Semantic proximity Read

Liver Fibrosis Conventional and Molecular Imaging Diagnosis UpdateSemantic proximity Read

Transcriptomic signatures of progressive and regressive liver fibrosis and portal hypertensionSemantic proximity Read

Steatosis Non-Invasive Tests Accurately Predict Metabolic Dysfunction-Associated Steatotic Liver Disease, While Fibrosis Non-Invasive Tests Fall Short: Validation in U.S. Adult PopulationSemantic proximity Read

GTX-11 improves portal hypertension, liver fibrosis, and sinusoidal cells phenotype in experimental MASHSemantic proximity Read